1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of Administration, by End User, by Geography Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024

Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of Administration, by End User, by Geography Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024

  • March 2019
  • 175 pages
  • ID: 5775428
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Wet Age-Related Macular Degeneration (AMD) Market by Product (Lucentis, Eylea, Avastin), by Distribution Channel (Direct, Indirect), by Age Group (Above 80 Years, 6080 Years, 4059 Years), by Route of Administration (Intravitreal, Intravenous), by End User (Hospitals & Clinics, Research & Academic Institutes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Russia, Sweden, Norway, Belgium, Switzerland, Austria, China, Japan, India, South Korea, Malaysia, Thailand, Australia, Singapore, Brazil, Mexico, Argentina, Colombia, Israel, South Africa, Saudi Arabia) Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024

According to the report, the global wet age-related macular degeneration (AMD) market attained a size of $6.9 billion in 2018, and it is expected to reach $10.4 billion by 2024, advancing at a CAGR of 7.1% during the forecast period (2019–2024). The growth of the market is driven by the rising prevalence of AMD, lack of a specific treatment, and increasing aging population.

Eylea, Lucentis, and Avastin are the drugs available worldwide for the treatment of wet AMD. Out of these, Eylea is anticipated to dominate the market in 2019–2024. The major factors escalating the demand for this drug in the global wet age-related macular degeneration market are the rising prevalence of AMD.

On the basis of route of administration, the market is bifurcated into intravenously and intravitreally given drugs. During the forecast period, the drugs administered through the intravitreal route are predicted to witness the faster growth at a CAGR of 7.2% in the global wet age-related macular degeneration market.

In 2018, North America held the largest revenue share, amounting to nearly $3.0 billion, in the global wet age-related macular degeneration market. This is ascribed to the increasing prevalence of wet AMD, rising number of drug approvals, and considerable presence of key players in the country.

On a global ground, during the 2019–2024 period, the market is projected to observe the fastest growth with a CAGR of 8.8% in APAC, owing to the surge in the aging population, increase in the prevalence of AMD, and reimbursements offered by the government for treating wet age-related macular degradation in the region.

Furthermore, APAC accounts for over one-third of the macular degeneration cases registered across the globe, which is anticipated to further rise during the forecast period. According to United Nations projections, nearly 24.0% of Asians will be of 60 years or above by 2050. Since aged people are more likely to develop AMD, the demand for medication for disease treatment is predicted to substantially rise in the region, resulting in the growth of the wet age-related macular degeneration market.

Also, wet AMD treatment is quite expensive, as a result of which the government of countries such as South Korea and Malaysia have introduced some health insurance plans to cover the cost of the treatment to some extent and to lessen the burden of healthcare on people. For instance, under the universal government health insurance plan of South Korea’s, during their lifetime, wet AMD patients can get up to 10 injections of ranibizumab. Thus, the increasing government initiatives are boosting the wet age-related macular degeneration market growth in the APAC region.

WET AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION
Market Segmentation by Product
• Lucentis
• Eylea
• Avastin
• Others

Market Segmentation by Distribution Channel
• Direct
• Indirect

Market Segmentation by Age Group
• Above 80 Years
• 60–80 Years
• 40–59 Years

Market Segmentation by Route of Administration
• Intravitreal
• Intravenous

Market Segmentation by End User
• Hospitals and Clinics
• Research and Academic Institute

Market Segmentation by Geography
• North America Wet AMD Market

- By product
- By distribution channel
- By age group
- By route of administration
- By end user
- By country – U.S. and Canada

• Europe Wet AMD Market

- By product
- By distribution channel
- By age group
- By route of administration
- By end user
- By country – Germany, U.K., France, Italy, Spain, Russia, Sweden, Norway, Belgium, Switzerland, Austria, and Rest of Europe

• Asia-Pacific (APAC) Wet AMD Market

- By product
- By distribution channel
- By age group
- By route of administration
- By end user
- By country – Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, and Rest of APAC

• Latin America (LATAM) Wet AMD Market

- By product
- By distribution channel
- By age group
- By route of administration
- By end user
- By country – Brazil, Mexico, Argentina, Colombia, and Rest of LATAM

• Middle East and Africa (MEA) Wet AMD Market

- By product
- By distribution channel
- By age group
- By route of administration
- By end user
- By country — Israel, South Africa, Saudi Arabia, and Rest of MEA

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Financial Wellness Benefits Market in US - Industry Outlook and Forecast 2019-2024

Financial Wellness Benefits Market in US - Industry Outlook and Forecast 2019-2024

  • $ 4250
  • May 2019

The US financial wellness benefits market is expected to cross $825 million by 2024, growing at a CAGR close to 13% during the forecast period.The US financial wellness benefits market is driven by the ...

Global Elderly and Disabled Assistive Solutions Market 2019-2023

Global Elderly and Disabled Assistive Solutions Market 2019-2023

  • $ 2500
  • May 2019

About this marketSeveral growing initiatives by governments and NGOs for promoting the awareness about physical disabilities among the people is driving the elderly and disabled assistive solutions market ...

Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application, By Product, By Region And Segment Forecasts, 2019 - 2025

Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application, By Product, By Region And Segment Forecasts, 2019 - 2025

  • $ 4950
  • April 2019

Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Isoflurane, Desflurane), By Region, And Segment Forecasts, 2019 - 2025The ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on